Searchable abstracts of presentations at key conferences in endocrinology

ea0056s23.3 | Pre-diabetes | ECE2018

Treatment of Pre-Type 2 Diabetes

Bonadonna Riccardo

Pre-Type 2 Diabetes has not a commonly shared definition. In this talk, the term will be used to indicate people with impaired fasting glucose and/or impaired glucose tolerance and no evidence of pancreatic beta cell autoimmunity. These people are known to be at increased risk of cardiovascular disease/mortality, yet it it is still unclear whether this abnormal risk can be accounted for by the concomitant presence of well recognized risk indicators/factors, most of which are c...

ea0081p593 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Hyperglycemia, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19

Eletto Elisa , Dei Cas Alessandra , Nouvenne Antonio , Ticinesi Andrea , Prati Beatrice , Spigoni Valentina , Aldigeri Raffaella , Cinquegrani Gloria , Schiro Silvia , Ruffini Livia , Sverzellati Nicola , Meschi Tiziana , Bonadonna Riccardo C.

Background: Both diabetes mellitus and hyperglycemia are reported to be strong risk factors for poor outcome(s) in patients hospitalized for COVID-19. However, their relative roles in affecting patient prognosis are under debate.Aims: To evaluate the independent influence of known diabetes mellitus and hyperglycemia on death/admission to intensive care unit (ICU) in patients hospitalized for COVID-19 during the first wave of SARS-Co-V2 pandemic.<p cl...